While in general, ATG gene mutations are rare in cancer, data inferred from a large cohort of human melanoma patients revealed low expression levels of ATG5, a critical factor for autophagosome membrane expansion, in primary tumors compared to benign nevi, which correlates with impaired autophagic activity and reduced progression-free survival in patients [31]. The gene discussed is ATG5; the disease is melanoma.